Suggestions
Gad Berdugo
Biotech Leader with extensive experience in global business & corporate development, operations, strategy, finance, investments and venture management - Chief Executive Officer - Chief Business Officer - Board Member
Gad Berdugo is an accomplished biotechnology C-level executive with a background in global business and corporate development.
He has extensive experience in strategy, operations, finance, investments, and venture management.
Berdugo leverages exceptional leadership and communication skills to formulate and implement business strategies, as well as to build high-performance teams.
His specialties include biotechnology, biopharmaceuticals, cancer immunotherapy, precision & personalized medicine, molecular diagnostics, gene & cellular therapies, and gene editing.
Education-wise, he has studied at prestigious institutions like Northwestern University, HEC School of Management, University College London, and Imperial College London.
Berdugo has held key positions like Vice Chairman of the Board of Directors at DIACCURATE and Chief Business Officer at Editas Medicine.
He was also the Chief Executive Officer and Co-Founder of EpiVax Oncology Inc., and has held roles at companies like IMMUNE Pharmaceuticals Inc., Tegris LLC, and Lazard.
Gad Berdugo's background encompasses expertise in business and corporate development, venture management, strategic partnerships, M&A, financing, Nasdaq listing, due diligence, valuation, investments, leadership, and team building.
